Filana Therapeutics, Inc. (FLNA) Earnings History
Net Loss27 years of earnings data (1999–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Filana Therapeutics, Inc. (FLNA) Earnings Overview
As of November 8, 2026, Filana Therapeutics, Inc. (FLNA) reported trailing twelve-month net income of -$42M, reflecting -28.8% year-over-year growth. The company earned $-0.87 per diluted share over the past four quarters.
Looking at the long-term picture, FLNA's historical earnings data spans multiple years. The company achieved its highest annual net income of $32M in fiscal 2013.
Filana Therapeutics, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ACAD ($362M net income, 36.5% margin), PRAX (-$339M net income), ATNM ($11M net income, -37652.2% margin), FLNA has comparable earnings metrics. Compare FLNA vs ACAD →
FLNA Earnings vs Peers
Earnings metrics vs comparable public companies
FLNA Historical Earnings Data (1999–2025)
27 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$91M | -273.7% | -$95M | $-1.88 | - | - |
| 2024 | -$24M | +75.0% | -$141M | $-1.46 | - | - |
| 2023 | -$97M | -27.5% | -$106M | $-2.32 | - | - |
| 2022 | -$76M | -135.4% | -$80M | $-1.90 | - | - |
| 2021 | -$32M | -411.3% | -$33M | $-0.82 | - | - |
| 2020 | -$6M | -36.8% | -$11M | $-0.24 | - | - |
| 2019 | -$5M | +29.4% | -$10M | $-0.27 | - | - |
| 2018 | -$7M | +45.0% | -$7M | $-0.61 | - | - |
| 2017 | -$12M | +19.8% | -$12M | $-1.82 | - | - |
| 2016 | -$15M | -5.0% | -$15M | $-2.31 | - | - |
| 2015 | -$14M | -14.2% | -$14M | $-2.16 | - | - |
| 2014 | -$12M | -139.3% | -$12M | $-1.92 | - | - |
| 2013 | $32M | +1015.4% | $31M | $4.90 | 76.7% | 76.3% |
| 2012 | -$3M | -31.9% | -$4M | $-0.54 | -31.6% | -35.8% |
| 2011 | -$3M | +78.3% | -$4M | $-0.41 | -22.8% | -30.6% |
| 2010 | -$12M | -246.8% | -$14M | $-1.97 | -71.5% | -81.5% |
| 2009 | -$3M | -122.6% | -$7M | $-0.58 | -16.9% | -32.8% |
| 2008 | $15M | -24.4% | $9M | $2.45 | 24.1% | 13.7% |
| 2007 | $20M | +228.1% | $10M | $3.08 | 30.8% | 15.4% |
| 2006 | $6M | +120.2% | $-553,000 | $0.98 | 11.5% | -1.0% |
| 2005 | -$31M | +18.8% | -$33M | $-4.90 | -603.7% | -644.0% |
| 2004 | -$38M | -74.8% | -$39M | $-7.10 | - | - |
| 2003 | -$22M | -35.7% | -$22M | $-5.13 | - | - |
| 2002 | -$16M | -11.1% | $17M | $-4.12 | -13969.3% | 14841.2% |
| 2001 | -$14M | +18.0% | -$17M | $-3.96 | - | - |
| 2000 | -$17M | -288.5% | -$20M | $-5.01 | - | - |
| 1999 | -$4M | - | -$5M | $-0.09 | - | - |
Download Data
Export FLNA earnings history in CSV or JSON format
Free sign-in required to download data
FLNA Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
27+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
FLNA — Frequently Asked Questions
Quick answers to the most common questions about buying FLNA stock.
What is FLNA earnings per share (EPS)?
FLNA trailing twelve-month (TTM) diluted EPS is $-0.87, reflecting -28.8% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 1999 to 2025 is available in the table on this page.
What is Filana Therapeutics, Inc.'s net income?
Filana Therapeutics, Inc. (FLNA) trailing twelve-month net income is $-42M as of 2025. Earnings declined -28.8% year-over-year.
Is FLNA profitable?
FLNA is not currently profitable on a TTM basis, reporting a net loss of $-42M. Net margin is N/A. Investors should monitor for a return to profitability.
What is FLNA's earnings growth rate?
FLNA compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1999 to 2025.
What are FLNA's profit margins?
Filana Therapeutics, Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -82.7%.
Is FLNA growing earnings?
FLNA earnings are declining — EPS fell -28.8% year-over-year. TTM net income dropped to $-42M. This contrasts with the 5-year CAGR of N/A.
What was FLNA's best earnings year?
Filana Therapeutics, Inc.'s highest annual net income on record is $32M, achieved in fiscal year 2013. Earnings history on this page spans 1999 to 2025 and includes all annual and quarterly figures.
What were FLNA's earnings last quarter?
FLNA's most recent reported quarter was Q3 2026. Net income was $-11M with diluted EPS of $-0.22. For a full breakdown of all quarters, see the quarterly earnings table on this page.